Tetanus Toxin-ACVA Fusion Vaccine

N/A

Report date: 2022/03/04 09:16:55

Base Information

Drug NameTetanus Toxin-ACVA Fusion Vaccine
Drug Alias NameDNA fusion vaccine (CEA-expressing tumors)pDOM-CAP-1 (ACVA)pDOM-CAP-1
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulantsCarcinoembryonic antigen modulators
TargetsCarcinoembryonic antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research UK
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A